Form 4: Elanco CEO Jeffrey Simmons Acquires Additional Deferred Stock Units

Elanco Animal Health Inc.'s President, CEO, and Director, Jeffrey N. Simmons, acquired 206.0446 deferred stock units on May 30, 2025, increasing his direct beneficial ownership.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired 206.0446 Deferred Stock Units (DSUs).
• The transaction occurred on May 30, 2025.
• Each DSU represents the right to receive one share of Company common stock or the cash equivalent.
• The acquisition price per DSU was $13.44.
• Following this transaction, Mr. Simmons directly beneficially owns 16,455.1386 DSUs.
• DSUs settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The acquisition of additional deferred stock units by the CEO and Director is generally viewed as a positive signal of management's confidence in the company's future.

Positives

• The acquisition of additional deferred stock units by the CEO and Director, Jeffrey N. Simmons, may signal management's confidence in the company's future performance.
• The increase in beneficial ownership aligns management's interests with those of shareholders.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The acquisition of deferred stock units by Jeffrey N. Simmons, the President, CEO, and Director, is a related party transaction as it involves a key executive of the company.

Stakeholder Impact

• Shareholders: May view the insider acquisition as a positive indicator of management's belief in the company's value, potentially influencing investor sentiment.

Key Dates

Recommendation

Keywords

Elanco, ELAN, SEC Form 4, Insider Transaction, Deferred Stock Units, Executive Compensation, Jeffrey N. Simmons, Beneficial Ownership